These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

180 related articles for article (PubMed ID: 16691502)

  • 1. Sphingolipids, cholesterol, and HIV-1: a paradigm in viral fusion.
    Rawat SS; Viard M; Gallo SA; Blumenthal R; Puri A
    Glycoconj J; 2006 May; 23(3-4):189-97. PubMed ID: 16691502
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Functional expression of CD4, CXCR4, and CCR5 in glycosphingolipid-deficient mouse melanoma GM95 cells and susceptibility to HIV-1 envelope glycoprotein-triggered membrane fusion.
    Rawat SS; Eaton J; Gallo SA; Martin TD; Ablan S; Ratnayake S; Viard M; KewalRamani VN; Wang JM; Blumenthal R; Puri A
    Virology; 2004 Jan; 318(1):55-65. PubMed ID: 14972535
    [TBL] [Abstract][Full Text] [Related]  

  • 3. The role of cholesterol and sphingolipids in chemokine receptor function and HIV-1 envelope glycoprotein-mediated fusion.
    Ablan S; Rawat SS; Viard M; Wang JM; Puri A; Blumenthal R
    Virol J; 2006 Dec; 3():104. PubMed ID: 17187670
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Glycosphingolipids promote entry of a broad range of human immunodeficiency virus type 1 isolates into cell lines expressing CD4, CXCR4, and/or CCR5.
    Hug P; Lin HM; Korte T; Xiao X; Dimitrov DS; Wang JM; Puri A; Blumenthal R
    J Virol; 2000 Jul; 74(14):6377-85. PubMed ID: 10864648
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Elevated expression of GM3 in receptor-bearing targets confers resistance to human immunodeficiency virus type 1 fusion.
    Rawat SS; Gallo SA; Eaton J; Martin TD; Ablan S; KewalRamani VN; Wang JM; Blumenthal R; Puri A
    J Virol; 2004 Jul; 78(14):7360-8. PubMed ID: 15220409
    [TBL] [Abstract][Full Text] [Related]  

  • 6. An inhibitor of glycosphingolipid metabolism blocks HIV-1 infection of primary T-cells.
    Puri A; Rawat SS; Lin HM; Finnegan CM; Mikovits J; Ruscetti FW; Blumenthal R
    AIDS; 2004 Apr; 18(6):849-58. PubMed ID: 15060432
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Cell type-specific fusion cofactors determine human immunodeficiency virus type 1 tropism for T-cell lines versus primary macrophages.
    Alkhatib G; Broder CC; Berger EA
    J Virol; 1996 Aug; 70(8):5487-94. PubMed ID: 8764060
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Role of cholesterol in human immunodeficiency virus type 1 envelope protein-mediated fusion with host cells.
    Viard M; Parolini I; Sargiacomo M; Fecchi K; Ramoni C; Ablan S; Ruscetti FW; Wang JM; Blumenthal R
    J Virol; 2002 Nov; 76(22):11584-95. PubMed ID: 12388719
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Role of glycosphingolipids in HIV-1 entry: requirement of globotriosylceramide (Gb3) in CD4/CXCR4-dependent fusion.
    Puri A; Hug P; Jernigan K; Rose P; Blumenthal R
    Biosci Rep; 1999 Aug; 19(4):317-25. PubMed ID: 10589997
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Different requirements for membrane fusion mediated by the envelopes of human immunodeficiency virus types 1 and 2.
    Dragic T; Alizon M
    J Virol; 1993 Apr; 67(4):2355-9. PubMed ID: 8095307
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Human immunodeficiency virus type 1 Env with an intersubunit disulfide bond engages coreceptors but requires bond reduction after engagement to induce fusion.
    Abrahamyan LG; Markosyan RM; Moore JP; Cohen FS; Melikyan GB
    J Virol; 2003 May; 77(10):5829-36. PubMed ID: 12719576
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Restricted lateral mobility of plasma membrane CD4 impairs HIV-1 envelope glycoprotein mediated fusion.
    Rawat SS; Zimmerman C; Johnson BT; Cho E; Lockett SJ; Blumenthal R; Puri A
    Mol Membr Biol; 2008 Jan; 25(1):83-94. PubMed ID: 18097956
    [TBL] [Abstract][Full Text] [Related]  

  • 13. HIV-1 envelope glycoprotein-mediated fusion and pathogenesis: implications for therapy and vaccine development.
    Jacobs A; Garg H; Viard M; Raviv Y; Puri A; Blumenthal R
    Vaccine; 2008 Jun; 26(24):3026-35. PubMed ID: 18242797
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Segregation of CD4 and CXCR4 into distinct lipid microdomains in T lymphocytes suggests a mechanism for membrane destabilization by human immunodeficiency virus.
    Kozak SL; Heard JM; Kabat D
    J Virol; 2002 Feb; 76(4):1802-15. PubMed ID: 11799176
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Requirement of nef for HIV-1 infectivity is biased by the expression levels of Env in the virus-producing cells and CD4 in the target cells.
    Tobiume M; Tokunaga K; Kiyokawa E; Takahoko M; Mochizuki N; Tatsumi M; Matsuda M
    Arch Virol; 2001; 146(9):1739-51. PubMed ID: 11699959
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Role of glycosphingolipid microdomains in CD4-dependent HIV-1 fusion.
    Fantini J; Hammache D; Piéroni G; Yahi N
    Glycoconj J; 2000; 17(3 -4):199-204. PubMed ID: 11201791
    [TBL] [Abstract][Full Text] [Related]  

  • 17. HIV Env reduction postreceptor binding: a new target for AIDS treatment?
    Fenouillet E; Barbouche R; Jones IM
    Blood; 2004 Jul; 104(1):296. PubMed ID: 15208211
    [No Abstract]   [Full Text] [Related]  

  • 18. Real-time analysis of human immunodeficiency virus type 1 Env-mediated membrane fusion by fluorescence resonance energy transfer.
    Furuta RA; Nishikawa M; Fujisawa J
    Microbes Infect; 2006 Feb; 8(2):520-32. PubMed ID: 16300985
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Cell-cell fusion assay to study role of chemokine receptors in human immunodeficiency virus type 1 entry.
    Rucker J; Doranz BJ; Edinger AL; Long D; Berson JF; Doms RW
    Methods Enzymol; 1997; 288():118-33. PubMed ID: 9356991
    [No Abstract]   [Full Text] [Related]  

  • 20. HIV-1 gp41 six-helix bundle formation occurs rapidly after the engagement of gp120 by CXCR4 in the HIV-1 Env-mediated fusion process.
    Gallo SA; Puri A; Blumenthal R
    Biochemistry; 2001 Oct; 40(41):12231-6. PubMed ID: 11591141
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 9.